Elite Pharmaceuticals (ELTP) EBT (2010 - 2026)
Elite Pharmaceuticals (ELTP) reported EBT of $7.72 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$564,214 a year earlier and down 63.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) EBT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' EBT came in at $65.1 million; for FY2026 (ended Mar 31, 2026), it was $56.81 million.
- EBT has a five-year compound annual growth rate of 68.8% (FY2021 to FY2026).
- By fiscal year, EBT came in at -$100,000 in FY2025, $500,000 in FY2024 (-87.5%), $3.99 million in FY2023 (-36.8%) and $6.3 million in FY2022 (+52.1%).
- Five-year quarterly EBT spans a low of -$10.65 million in fiscal Q3 2025 and a high of $20.85 million in fiscal Q4 2026.
- The high point for year-over-year EBT in five years was fiscal Q4 2025 (growth of 846.9%); the low point was fiscal Q1 2023 (a decline of 80.1%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $20.85 million (Q4 2026), $20.83 million (Q3 2026) and $15.69 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | 7.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.72 Mn |
| Mar 31, 2026 | 20.85 Mn |
| Dec 31, 2025 | 20.83 Mn |
| Sep 30, 2025 | 15.69 Mn |
| Jun 30, 2025 | -564,214.00 |
| Mar 31, 2025 | 19.22 Mn |
| Dec 31, 2024 | -10.65 Mn |
| Sep 30, 2024 | -9.52 Mn |
| Jun 30, 2024 | 847,752.00 |
| Mar 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | -94,259.00 |
| Sep 30, 2023 | -2.73 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | -856,063.00 |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 305,883.00 |
| Mar 31, 2022 | 688,300.00 |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | 1.80 Mn |
API Access
Elite Pharmaceuticals EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();